The Hon Greg Hunt MP, Minister for Industry, Innovation and Science, has announced seed funding from the Medical Technologies and Pharmaceuticals Industry Growth Centre Project Fund Program for an exciting new Australia-wide consortium that promises to bring new treatments closer.
The consortium is focused on collaboration to develop a culture of innovation that supports the progression of Australian medical research through to real world outcomes, through the provision of a mentoring network and training programmes adapted from global best practice in innovation and entrepreneurship.
The Consortium partners at inception are the Centre for Entrepreneurial Research and Innovation (CERI), The University of Western Australia, Monash University, University of Sydney, SPARK Co-Lab Ltd, University of Technology Sydney, Proteomics International Limited, Orthocell Ltd, St John of God Healthcare, Avita Medical, University of Adelaide, Murdoch University, Curtin University, Edith Cowan University, Harry Perkins Institute of Medical Research, Telethon Kids Institute, Lion’s Eye Institute, Ear Science Institute Australia and the WA Neuroscience Research Institute.
Chair of the Consortium Steering Committee, Associate Professor Kevin Pfleger said, “we owe it to the community to translate research as effectively as possible and this Australia-wide collaboration between industry, healthcare providers and academia will take an important step towards that goal.”
The Consortium would like to thank MTPConnect for their support of this initiative through their competitive matched funding program that aims to invest in big, bold ideas to boost the innovation, productivity and competitiveness of Australia’s MTP sector.
The Consortium’s funding is part of the $7.4m going to 14 projects over two years through the Project Fund Program.
Sue MacLeman, CEO of MTPConnect said, “We are very excited to be supporting this impressive national consortium led by the Centre for Entrepreneurial Research and Innovation.
Development of this project will ensure that it is set to drive change through collaboration and innovation, two important pillars of the MTPConnect Sector Competitiveness Plan.
Translational research and training is essential for the future growth and competitiveness of the medtech and pharmaceuticals sector in Australia, to ensure that we can flourish on both a local and global scale.”